1THM Biomedical, Inc., Duluth, Minnesota 55802, USA. jhbdlh@cpinternet.com
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
This study details a novel bioresorbable bone graft substitute (BGS) using polylactic acid, hyaluronic acid, and bone morphogenetic protein 2. In vivo testing demonstrated its efficacy in bone regeneration, offering a promising alternative for skeletal repair.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: